Lexagene Holdings Inc V.LXG

Primary Symbol: LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > WCVB Boston tonight COVID-19 Story

<< Previous

Bullboard Posts

Next >>

Comment by 007daveon Mar 04, 2020 2:45pm

97 Views

Post# 30766628

RE:RE:WCVB Boston tonight COVID-19 Story

He said his company is developing a testing instrument, the LX2, that could yield results on a COVID-19 sample much more quickly than a government laboratory. That was a good news piece on LXG. I Dr Regan is a very bright man but could be more of a salesman. " Is developing" I thought they HAVE developed a testing instrument and "could yield results" am I wrong or have they have successfully tested for Coronavirus. LEXAGENE S LX ANALYZER SUCCESSFULLY DETECTS CORONAVIRUS RNA USING THE CDC S TESTS. From February 20 NR.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages